4//SEC Filing
BRODIE STEVEN G. 4
Accession 0001209191-18-014673
CIK 0001077183other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:37 PM ET
Size
12.0 KB
Accession
0001209191-18-014673
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-26$8.03/sh+58,000$465,740→ 58,000 totalExercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (58,000 underlying)
Holdings
- 32,619
Common Stock
- 13,334
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (13,334 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]On March 5, 2014, Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date. On July 5, 2017, Dr. Brodie exercised 6,666 options leaving a balance of 13,334.
- [F2]On May 4, 2015, Dr. Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F3]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F5]On February 26, 2018, Dr. Brodie was granted 58,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001640522
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:37 PM ET
- Size
- 12.0 KB